Collegium Pharmaceutical (COLL) Stock Price, Quote, News & History | Benzinga

Collegium Pharmaceutical Inc (COLL) Stock Price, Quote, News & History

COLLNASDAQ

Trade with Public

Trade with Public

$25.35

-1.09-4.12%

At close: Aug 28, 5:00 PM EST

$25.35

N/A

After Hours: Aug 28, 4:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$26.32

Close

$25.35

Volume / Avg.

813.95K / 546.57K

Day Range

$25.16 - $26.69

52 Wk Range

25.47 - 50.79

Market Cap

$785.83M

P/E Ratio

20.78

Dividend Yield

-

Exchange

NASDAQ

RSI

28

Short Interest

25.39%

Days to Cover

6.66

Recent Collegium Pharmaceutical Inc News

5 Hot Stocks With Summer Buybacks You Can Cash In On

Stock buybacks remain one of the most effective tools for boosting share prices, especially when backed by solid fundamentals. When a company is healthy, repurchasing shares reduces the float, enhances earnings per

MarketBeat

Collegium's Revenue Outlook And CNS Expansion Signal Undervalued Opportunity, Says Needham

Needham analyst upgrades Collegium Pharmaceutical to Buy with a $46 target, citing strong 2025 guidance, growth potential, and undervaluation.

Nabaparna Bhattacharya

S&P Global To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday

Avi Kapoor

Why Collegium Pharmaceutical Shares Are Gaining Today

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) today announced FY24 financial

Akanksha Bakshi

TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday

U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during Wednesday’s session after it disclosed receiving a preliminary non-binding acquisition offer.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

329.92M

Investing Cash Flow (TTM)

-551.90M

Financing Cash Flow (TTM)

234.11M

Free Cash Flow (TTM)

328.28M

Capital Expenditure (TTM)

-1.64M

Net Change in Cash (TTM)

12.13M

Analyst Trends and Forecast

2

Mar

2

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.79B

PE Ratio (TTM)

20.78

PE Ratio (FWD)

3.56

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.18

PB Ratio (TTM)

2.75

Earnings Yield % (TTM)

4.81%

Earnings Yield % (FWD)

28.12%

EV / EBITDA (TTM)

4.71

Price / EBITDA (TTM)

2.46

Price / Free Cash Flow (TTM)

2.91

Book Value / Share

$9.58

Company Debt

Total Debt

$1.09B

LT Debt

$1.04B

LT Debt Issuance (TTM)

$864.68M

LT Debt Repayment (TTM)

-$617.77M

Total Cash

$129.47M

Debt to Equity

3.52

Issuance of Debt (TTM)

$246.91M

Repayment of Debt (TTM)

-$617.77M

Key Statistics

Open

$26.32

Close

$25.35

Volume / Avg.

813.95K / 546.57K

Day Range

$25.16 - $26.69

52 Wk Range

25.47 - 50.79

Market Cap

$785.83M

P/E Ratio

20.78

Dividend Yield

-

Exchange

NASDAQ

RSI

28

Short Interest

25.39%

Days to Cover

6.66

About

Sector

Health Care

Industry

Pharmaceuticals

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated pr...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Collegium Pharmaceutical (COLL) stock?

A

You can purchase shares of Collegium Pharmaceutical (NASDAQ:COLL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Collegium Pharmaceutical (COLL) competitors?

A

Other companies in Collegium Pharmaceutical’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Collegium Pharmaceutical (COLL) stock?

A

Collegium Pharmaceutical has a consensus price target of $47.00.

Q

What is the current price for Collegium Pharmaceutical (COLL)?

A

The stock price for Collegium Pharmaceutical (NASDAQ: COLL) is $25.35 last updated August 28, 2026 at 4:00 PM EDT.

Q

Does Collegium Pharmaceutical (COLL) pay a dividend?

A

There are no upcoming dividends for Collegium Pharmaceutical.

Q

When is Collegium Pharmaceutical (NASDAQ:COLL) reporting earnings?

A

Collegium Pharmaceutical does not have any upcoming earnings scheduled.

Q

Is Collegium Pharmaceutical (COLL) going to split?

A

There is no upcoming split for Collegium Pharmaceutical.

Q

What sector and industry does Collegium Pharmaceutical (COLL) operate in?

A

Collegium Pharmaceutical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.